Home › Freenome Raises $65M in Series A Funds

Freenome Raises $65M in Series A Funds

Mar 01, 2017

NEW YORK (GenomeWeb) – Palo Alto, California-based Freenome announced today that it has raised $65 million in Series A funding, which it will put toward conducting clinical trials to validate its non-invasive, early cancer detection technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Aug
27
Featured Webinar

Case Study: Genetic Testing Lab Sees 25-Fold Scaleup with New Informatics System

Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sep
17
Featured Webinar

Trends in Clinical NGS QC Management: Expert Insights to Ensure Quality Results for Your Lab

Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

What's Popular?

In Molecular Diagnostics

  1. China FDA Approves Novogene CDx Test for NSCLC Therapies

  2. Cell-Free DNA Screening, Invasive Testing Show Similar Miscarriage Rates, Study Suggests

  3. Natera Partners With Fox Chase to Evaluate ctDNA Cancer Assay

  4. OnSiteGene Developing Ultra-Fast qPCR System for Rapid Syndromic Testing

    Premium

  5. Genetic Technologies Announces Planned Chinese Joint Venture

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.